Novo Holdings A/S’s Harmony Biosciences HRMY Stock Holding History

Novo Holdings A/S’s Portfolio HRMY Stock Details HRMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,000	Closed	-$1.53M	–	50
2021 Q3	$1.53M	Sell	40,000 -1,382,953	-97%	-$44.5M	0.08%	48
2021 Q2	$40.2M	Sell	1,422,953 -1,913,425	-57%	-$57.4M	1.78%	17
2021 Q1	$110M	Sell	3,336,378 -286,093	-8%	-$10M	4.55%	8
2020 Q4	$131M	Sell	3,622,471 -132,502	-4%	-$5.35M	5.61%	6
2020 Q3	$127M	Buy	+3,754,973	New	+$137M	6.32%	4

Other funds holding HRMY

Valor Management Chicago, Illinois $181M AUM 6.67% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Newlight Partners New York $3.9M AUM 96.05% 1-Year Est. Return

Novo Holdings A/S's HRMY Position: Q4 2021 in Review

Novo Holdings A/S sold out of Harmony Biosciences (HRMY) in Q4 2021, closing a stake of 40,000 shares — an estimated $1.53M sold.

Novo Holdings A/S first reported a position in HRMY in Q3 2020 and held it in 5 quarters. The position peaked at $131M in Q4 2020. 147 funds tracked by Wall St. Rank hold HRMY as of Q4 2021.

Novo Holdings A/S reported no remaining Harmony Biosciences position as of Q4 2021 after selling out during the quarter.
Novo Holdings A/S sold 40,000 Harmony Biosciences shares in Q4 2021, an estimated $1.53M.
Novo Holdings A/S first reported a position in Harmony Biosciences in Q3 2020 and held it in 5 quarters.
Novo Holdings A/S's Harmony Biosciences position peaked at $131M in Q4 2020.
147 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2021.

Based on Novo Holdings A/S's 13F filing for Q4 2021, filed 14 Feb 2022.